Conduit secures a composition of matter patent from the USPTO for its lead asset, AZD1656, a Glucokinase Activator targeting autoimmune disorders, positioning the Company for clinical development and ...

Some of the common autoimmune diseases that are quite familiar to the public are Type 1 Diabetes Mellitus, Vitiligo, Psoriasis, Myositis, Multiple Sclerosis, Vasculitis, etc. Salient ...

In immune-mediated inflammatory diseases, the overall risk for serious adverse events is not notably higher with combo ...

Nkarta is laying off a third of its employees, including half of the biotech’s executive leadership, as the company diverts ...

Discover Nkarta's groundbreaking cell therapy advancements, robust financials, and investment potential. Click here to read ...

Did you know men and women's heart cells prefer different kinds of fuel? Gender differences are emerging as scientists turn ...

Family, friends, and fans continue to send prayers for the Queen of All Media, Kris Aquino, after she revealed a concerning ...

Rheumatologists and cardiologists have long co-managed patients out of necessity and without much formal collaboration or ...

Indian paediatric rheumatologists discuss early diagnosis and management of rheumatic disorders in children to prevent organ ...

including NKX019 for the treatment of autoimmune diseases, such as lupus, systemic sclerosis, myositis, vasculitis, and myasthenia gravis; the expected cost associated with and impact of the ...

Sana revolutionizes treatments for diabetes, cancer, and autoimmune diseases. SANA has high cash burn and dilution risks. See ...